
Clarient Helps Deliver an AI-Enabled Hereditary Cancer Risk Platform Reaching 21 Million Patients
Clarient, a global AI-native tech company, announced today a platform that improves early detection and empowers patients to act on hereditary cancer risk. NEW YORK, NY, UNITED STATES, April 29, 2025 /EINPresswire.com/ -- Clarient, a global AI- …